Start
Entdecken
nav.journalClub
Trends
Mehr
synapse
⌘+K
Sprache
Deutsch
Deutsch
Off-Label Dapagliflozin After Atrial Fibrillation Ablation: A Reasonable Intervention or Overstretching the Evidence? | Synapse
February 28, 2026
Off-Label Dapagliflozin After Atrial Fibrillation Ablation: A Reasonable Intervention or Overstretching the Evidence?
YC
Yang Chen
University of Liverpool
SP
Sean D. Pokorney
Duke University
Key Points
Key points are not available for this paper at this time.
Read Full Paper
externally
Mark Helpful
Like
Save
Bookmark
Relay
Share
View Full Paper
Mark Helpful
Like
Save
Bookmark
Relay
Share
View Full Paper
Cite This Study
Copy
Chen et al. (Mon,) studied this question.
synapsesocial.com/papers/6a025a659cddff7633412be5
https://doi.org/https://doi.org/10.1161/circulationaha.125.078518